Retraction

Recurrent Glioblastoma: Where we stand

Paper Information

Record ID:
17264
Author(s):
Sanjoy Roy
Debarshi Lahiri
Tapas Maji
Jaydip Biswas
Journal:
South Asian Journal of Cancer ( Wolters Kluwer )
Publication Date:
February 08, 2016
Retraction Date:
December 21, 2017 (7.9 years years ago)
Subject:
Broad Categories:
Medicine
Specific Fields:
Medicine - Oncology
Institution:
Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
Country:
🇮🇳 India
Article Type:
Review Article
Publisher:
Wolters Kluwer
Open Access:
Yes
DOI:
10.4103/2278-330X.175953
PubMed ID:
26981507
Retraction PubMed ID:
29404292

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.4103/2278-330X.221358

Citations (85)

85
Total Citations
72
Post-Retraction
(84.7%)
8
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
15 Within 1 year
45 After 2+ years
2384 Days since retraction (latest)
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2024
2384 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Apr 2024
2311 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jan 2024
2202 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2023
2049 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2023
2049 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Apr 2023
1934 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Mar 2023
1917 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jan 2023
1854 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jan 2023
1837 days after retraction
Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy
Salah Dajani, Virginia Hill, John A. Kalapurakal et al. (8 authors)
Journal of Clinical Medicine Open Access
Published: Oct 2022
8 citations
1754 days after retraction
Artificial intelligence for multimodal data integration in oncology
Jana Lipková, Richard J. Chen, Bowen Chen et al. (13 authors)
Cancer Cell Open Access
Published: Oct 2022
376 citations
1745 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2022
1712 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2022
1692 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2022
1686 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2022
1673 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2022
1673 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2022
1670 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2022
1653 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Apr 2022
1587 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Mar 2022
1561 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Nov 2021
1428 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jul 2021
1293 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jun 2021
1283 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jun 2021
1281 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: May 2021
1254 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Apr 2021
1198 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Mar 2021
1196 days after retraction
Anticancer Mechanism of Curcumin on Human Glioblastoma
Shu Chyi Wong, Muhamad Noor Alfarizal Kamarudin, Rakesh Naidu
Nutrients Open Access
Published: Mar 2021
93 citations
1181 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jan 2021
1131 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Dec 2020
1085 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Oct 2020
1045 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Sep 2020
985 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2020
982 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2020
980 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Aug 2020
954 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jun 2020
913 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jun 2020
907 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Jun 2020
903 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: May 2020
869 days after retraction
Inhibition of Nrf2 might enhance the anti-tumor effect of temozolomide in glioma cells via inhibition of Ras/Raf/MEK signaling pathway
Wei Sun, Weihua Zhang, Jianyong Yu et al. (5 authors)
International Journal of Neuroscience
Published: May 2020
18 citations
868 days after retraction
The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
Anna Kirstein, Thomas E. Schmid, Stephanie E. Combs
Cancers Open Access
Published: Apr 2020
35 citations
859 days after retraction
Paper citing Epigenetic silencing of peroxisome proliferator-ac...
Unknown Authors
Unknown Journal
Published: Apr 2020
832 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Mar 2020
801 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Mar 2020
801 days after retraction
Paper citing Recurrent Glioblastoma: Where we stand...
Unknown Authors
Unknown Journal
Published: Feb 2020
778 days after retraction
Quick Stats
Total Citations: 85
Years Since Retraction: 7.9 years
Open Access: Yes
Last Checked: Never
Related Papers
New thyroid fine needle aspiration biopsy needle. Prospecti…
Clinical Endocrinology • 2 citations
Adenoma replacement due to invasion of a metastatic mass: A…
Interdisciplinary Neurosurgery • 2 citations
Application of VIP Care in Patients with Advanced Tumors in…
BioMed Research International • 4 citations
Identification of a Novel Risk Model: A Five-Gene Prognosti…
Evidence-Based Complementary and Alternative Medicine • 4 citations
Correlations between Clinical Characteristics and Prognosis…
Evidence-Based Complementary and Alternative Medicine • 7 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice